Convalescent Plasma Halved Hospitalizations for Outpatient COVID-19
Convalescent plasma reduced the need for hospitalization by half for outpatients with COVID-19, according to a nationwide, multicenter clinical trial led by Johns Hopkins Medicine.
Convalescent plasma reduced the need for hospitalization by half for outpatients with COVID-19, according to a nationwide, multicenter clinical trial led by Johns Hopkins Medicine.